WhiteOak Capital Pharma and Healthcare Fund
Holdings
59
Broad portfolio
Top 10 weight
46%
Concentration
Strategy
Active
Portfolio style
Equity
94%
Asset allocation
Portfolio
5Sectors2Large positions59.8%Top: Pharmaceuticals & Biotechnology0.0%Cash
Market-cap allocation
Large cap32%
Mid cap19%
Small cap41%
Asset allocation
Equity94%
Top holdings
Sun Pharmaceutical Industries LimitedEQUITY8.5%
Torrent Pharmaceuticals LimitedEQUITY7.8%
Laurus Labs LimitedEQUITY4.9%
Apollo Hospitals Enterprise LimitedEQUITY4.8%
Divi's Laboratories LimitedEQUITY3.9%
Max Healthcare Institute LimitedEQUITY3.8%
Cipla LimitedEQUITY3.7%
Sai Life Sciences LimitedEQUITY3.2%
Zydus Lifesciences LimitedEQUITY2.9%
Neuland Laboratories LimitedEQUITY2.9%
Sign in for free to unlock all 59 holdings →Portfolio insights
Portfolio read
- 94% equity.
- Large-cap exposure is 32%.
- Largest equity sector is Pharmaceuticals & Biotechnology at 59.8%.
Watchpoints
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 60%.
Generated from current fund metrics. Educational research only.
Peer comparison
Other funds in Sectoral Fund.
Explore comparable funds →Sector exposure
Showing top sectors from the current portfolio.
Healthcare Services27.4%